膀胱癌
医学
免疫疗法
转移
癌症
血管生成
化疗
疾病
临床试验
肿瘤科
癌症研究
内科学
作者
Yoo Goo Kang,Chelin Park,Heemin Lee,So-Jin Kang,Chunhoo Cheon,Bonglee Kim
出处
期刊:Pharmaceutics
[MDPI AG]
日期:2023-03-31
卷期号:15 (4): 1117-1117
被引量:3
标识
DOI:10.3390/pharmaceutics15041117
摘要
Bladder cancer (BC) is a heterogeneous disease that a tumor develops in the bladder lining and in some cases, the bladder muscle. Chemotherapy and immunotherapy are commonly used to treat bladder cancer. However, chemotherapy can cause burning and irritation in the bladder while BCG immunotherapy, which is the main type of intravesical immunotherapy for bladder cancer, can also cause burning in the bladder and flu-like symptoms. Thus, drugs originating from natural products have attracted much attention due to the reports that they have anti-cancer properties with low adverse effects. In this study, eighty-seven papers that dealt with natural products preventing or treating bladder cancer were reviewed. The studies were classified into the following mechanism: 71 papers on cell death, 5 papers on anti-metastasis, 3 papers on anti-angiogenesis, 1 paper on anti-resistance, and 7 papers on clinical trials. Most of the natural products that induced apoptosis up-regulated proteins such as caspase-3 and caspase-9. Regarding anti-metastasis, MMP-2 and MMP-9 are regulated frequently. Regarding anti-angiogenesis, HIF-1α and VEGF-A are down-regulated frequently. Nevertheless, the number of papers regarding anti-resistance and clinical trial are too few, so more studies are needed. In conclusion, this database will be useful for future in vivo studies of the anti-bladder cancer effect of natural products, in the process of selecting materials used for the experiment.
科研通智能强力驱动
Strongly Powered by AbleSci AI